Toshihiko Hirano Selected Research

Hematologic Neoplasms (Hematological Malignancy)

6/2018	Arsenic disulfide‑induced apoptosis and its potential mechanism in two‑ and three‑dimensionally cultured human breast cancer MCF‑7 cells.
12/2013	Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiko Hirano Research Topics

Disease

17	Leukemia 01/2021 - 05/2002
14	Neoplasms (Cancer) 01/2021 - 11/2003
13	Breast Neoplasms (Breast Cancer) 12/2020 - 01/2015
8	Myasthenia Gravis 09/2018 - 12/2003
8	Infections 06/2017 - 06/2006
5	Rheumatoid Arthritis 10/2021 - 03/2004
4	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2006
4	Necrosis 01/2020 - 04/2009
4	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2017 - 10/2007
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 09/2019
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 09/2019
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2010
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2014 - 01/2003
3	Cytomegalovirus Infections (Inclusion Disease) 06/2014 - 01/2012
3	Disease Progression 01/2012 - 01/2006
3	Melanoma (Melanoma, Malignant) 01/2012 - 06/2009
2	Triple Negative Breast Neoplasms 12/2020 - 01/2018
2	Death (Near-Death Experience) 03/2020 - 11/2018
2	Hypertension (High Blood Pressure) 07/2019 - 01/2017
2	Hematologic Neoplasms (Hematological Malignancy) 06/2018 - 12/2013
2	Acute Promyelocytic Leukemia 01/2018 - 07/2015
2	Pre-Eclampsia (Preeclampsia) 01/2017 - 04/2015
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 08/2014 - 01/2011
2	Septic Shock (Toxic Shock Syndrome) 10/2011 - 06/2006
2	Ulcer 07/2010 - 04/2009
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2009 - 04/2007
2	Fibrosis (Cirrhosis) 01/2009 - 01/2006
2	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2008 - 06/2006
2	Bacterial Infections (Bacterial Infection) 10/2007 - 06/2006
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2005 - 12/2003
2	Crohn Disease (Crohn's Disease) 05/2004 - 10/2002
2	Ulcerative Colitis 05/2004 - 07/2002
1	T-Cell Leukemia (Leukemia, T Cell) 05/2024
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2024

Drug/Important Bio-Agent (IBA)

23	GlucocorticoidsIBA 05/2024 - 07/2002
12	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021 - 05/2002
12	Tacrolimus (Prograf)FDA LinkGeneric 12/2019 - 12/2003
11	tetrandrineIBA 01/2021 - 11/2003
10	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2019 - 12/2003
9	Daunorubicin (Cerubidine)FDA LinkGeneric 05/2024 - 02/2003
9	arsenic disulfide (realgar)IBA 01/2020 - 02/2014
8	CytokinesIBA 01/2021 - 02/2010
7	MitogensIBA 10/2021 - 10/2008
7	Calcineurin InhibitorsIBA 09/2018 - 01/2006
7	Prednisolone (Predate)FDA LinkGeneric 10/2011 - 09/2002
6	Vitamin K 2 (Vitamin K2)IBA 10/2021 - 01/2018
6	Methylprednisolone FDA LinkGeneric 11/2020 - 09/2002
5	ArsenicIBA 01/2020 - 08/2017
5	arseniteIBA 01/2020 - 07/2015
5	SuperantigensIBA 01/2009 - 01/2006
4	cepharanthineIBA 01/2021 - 09/2019
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2004
4	Aligeron (AS 2)IBA 12/2011 - 02/2003
4	Messenger RNA (mRNA)IBA 05/2004 - 09/2002
3	Methotrexate (Mexate)FDA LinkGeneric 10/2021 - 01/2013
3	AlkaloidsIBA 01/2021 - 08/2017
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 04/2009
3	VitaminsIBA 10/2020 - 01/2012
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2020 - 09/2002
3	SteroidsIBA 12/2019 - 01/2005
3	Tyrosine (L-Tyrosine)FDA Link 07/2019 - 04/2015
3	Biomarkers (Surrogate Marker)IBA 06/2017 - 12/2013
3	Concanavalin AIBA 05/2017 - 06/2006
3	sofalcone (Solon)IBA 04/2015 - 04/2009
3	Arsenicals (Arsenic Compounds)IBA 11/2014 - 09/2011
3	Arsenic Trioxide (Trisenox)FDA Link 01/2013 - 02/2003
3	AntibodiesIBA 01/2012 - 02/2010
3	Cholinergic ReceptorsIBA 01/2012 - 02/2010
3	Staphylococcal enterotoxin FIBA 04/2007 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 04/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 08/2015
2	Interleukin-2 (IL2)IBA 01/2021 - 08/2015
2	Estrogen ReceptorsIBA 12/2020 - 01/2018
2	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 10/2020 - 01/2018
2	Vitamin K 3 (Menadione)FDA Link 10/2020 - 11/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 08/2020 - 07/2002
2	dicarboxydine (DCD)IBA 03/2020 - 11/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2013
2	Adenosine Triphosphate (ATP)IBA 06/2017 - 06/2014
2	Cholecalciferol (Vitamin D3)FDA Link 05/2017 - 01/2012
2	EndoglinIBA 01/2017 - 04/2015
2	Hormones (Hormone)IBA 08/2015 - 01/2015
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2014 - 01/2012
2	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2014 - 01/2012
2	Dacarbazine (DIC)FDA LinkGeneric 01/2013 - 01/2012
2	arsenic acid (arsenate)IBA 12/2011 - 09/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2011 - 01/2009
2	RoxithromycinIBA 10/2011 - 01/2009
2	Chalcone (Benzalacetophenone)IBA 06/2009 - 04/2009
2	Therapeutic UsesIBA 01/2005 - 12/2003
1	Inosine Triphosphate (ITP)IBA 05/2024
1	sinomenineIBA 01/2021
1	JNK Mitogen-Activated Protein KinasesIBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2018 - 01/2002
4	Kidney Transplantation 10/2016 - 04/2007
3	Drug Therapy (Chemotherapy) 09/2019 - 11/2003
3	Liver Transplantation 01/2009 - 01/2006
2	Renal Dialysis (Hemodialysis) 06/2017 - 04/2007